Top-Ranked Hospitals Have Better Survival Rates, But Not Necessarily A Lower Risk of Readmission
Cardiology patients treated in hospitals at the top of U.S. News & World…
Endocarditis Persists Five Years After Transcatheter Deployment of Melody Valve Prosthesis in Pulmonary Position
The results of a study conducted by Doff B. McElhinney and his…
Does Race/Ethnicity Affect Oral Anticoagulant Use in Patients With Atrial Fibrillation?
A study by Essien and his colleagues published in JAMA aimed to…
New TAVR Insights: Survival Advantage of TAVR Over SAVR Not Sustained At Five Years, Severe Prosthesis-Patient Mismatch Not Benign Following TAVR
The 5-year outcomes of a trial conducted by Gleason et al. published…
Coronary Physiology Beyond Coronary Flow Reserve: A Giant Leap in the Understanding of Coronary Microvascular Disease
In a JACC State-of-the-Art Review by Dr. Lance Gould and his colleagues…
NT-ProBNP-Guided Medical Therapy Failed To Show Superiority Compared To Usual Care In HFrEF
Results of a multi-center, randomized clinical trial which enrolled 894 patients with…
Diagnosis of Frailty in a Patient with Acute Myocardial Infarction Helps Personalize an Approach to Optimize Outcomes
In a report in this issue of the JACC: Cardiovascular Interventions, Dr.…
N- acetylcysteine and Intravenous Sodium Bicarbonate Infusion in the Prevention of Contrast Associated Kidney Injury: A Cautionary Tale
A study published in JACC Cardiovascular Interventions has shown that among patients…
Workplace Bullying and Violence Might be New, Potentially Modifiable Cardiovascular Risk Factors
A European study has revealed that bullying and violence are common at…
Mechanistic Study Delves Into Heart Failure Benefits Noted With Empagliflozin
The EMPA-HEART trial showed that empagliflozin resulted in beneficial effects on left…
TRED-HF: Tread With Caution While Withdrawing Heart Failure Medication in Recovered Dilated Cardiomyopathy
The results of the TRED-HF trial published in The Lancet showed that…
Does Low Dose Methotrexate Prevent Athersclerotic Events in Patients?
A randomized clinical trial that was conducted by Paul M Ridker et…
Canakinumab: A New Hope for Post MI Patients with Increased hsCRP in the Prevention of Heart Failure
Canakinumab (an IL-B inhibitor) is associated with decreased heart failure (HF) hospitalizations…
Superior Efficacy of Sacubitril-Valsartan Compared to Enalapril for lowering NT Pro-BNP in Patients Hospitalized for HFrEF
Results from a multi-center, randomized, double-blind, double dummy, parallel group clinical trial…
Dapaglifozin ‘DECLARED’ Effective in the Reduction of Heart Failure Hospitalizations in Diabetic Population
The DECLARE–TIMI 58 trial, published in the New England Journal of Medicine…
Saphenous Vein Graft Harvesting for CABG: Endoscopic Vs Open Technique
A new study published in the New England Journal of Medicine showed…
Fish Oil or Vitamin D Supplementation as Protection Against Cardiovascular Events or Cancer Suffers Deteriorating ‘VITAL’ Signs
The VITAL trial conducted by Manson et al. showed that supplementation with…
The Latest Incarnation of the Blood Cholesterol Management Guideline 2018: Numbers Matter, Lower LDL-C is better
The AHA/ACC 2018 guideline on the management of blood cholesterol, endorsed by…
Type 2 Diabetes: SGLT2 Inhibitors Demonstrate Robust Benefits on Cardiovascular and Renal Outcomes
The results of a study presented at AHA 2018 have shown that…
Fish Oil Use in Hypertriglyceridemia Reduces Risk of Ischemic Events, Over-The-Counter Fish Oil Supplements Still ‘Fishy’
A study by Bhatt et al. published online in the New England…